Mediastinal lymphnode positivity clinical scoring system for lung adenocarsinoma-mediastinal lymph node evaluation and staging-Reference-Cited by-同舟云学术

Mediastinal lymphnode positivity clinical scoring system for lung adenocarsinoma-mediastinal lymph node evaluation and staging

Published:2022-05-30 Issue:3 Volume:5 Page:831-838
ISSN:2636-8579
Container-title:Journal of Health Sciences and Medicine
language:en
Short-container-title:J Health Sci Med / JHSM

Author:

AĞABABAOĞLU İsmail¹,YİLDİZ Ozgur Omer²,YAPAR Dilek³,ERSÖZ Hasan⁴,HAZER Seray⁵,HELVACI Özant⁶,GÜLHAN Selim Şakir Erkmen⁵,KARAOGLANOGLU Nurettin²

Affiliation:

1. YILDIRIM BEYAZIT ÜNİVERSİTESİ

2. YILDIRIM BEYAZIT UNIVERSITY

3. GAZI UNIVERSITY

4. IZMIR KATIP CELEBI UNIVERSITY

5. UNIVERSITY OF HEALTH SCIENCES, ANKARA ATATÜRK HEALTH RESEARCH CENTER FOR PULMONOLOGY AND THORACIC SURGERY

6. Yıldırım Beyazıt Üniversitesi Yenimahalle Eğitim ve Araştırma Hastanesi

Abstract

Aim: The study-cohort aims to assess PET-CT's correlation with adenocarcinomas' subtypes and propose a scoring system for mediastinal lymph nodes staging. Material and Method: The patient cohort is a multicenter, retrospective analysis of 268 patient that underwent surgery for NSCLC adenocarcinoma. Preoperative PET-CT results for mediastinal lymph node staging was pathologically confirmed on tissue specimens obtained at anatomical resection. Statistical evaluation of PET CT, radiological and pathological outcomes were performed on all subgroups. Results: The low FDG affinity in the lepidic pattern was statistically significant in the study (p

Publisher

Journal of Health Sciences and Medicine

Subject

General Medicine

Reference29 articles.

1. Hochhegger B, Alves GR, Irion KL, et al. PET/CT imaging in lung cancer: indications and findings. J Bras Pneumol 2015 May-Jun; 41: 264-74.

2. Zhao L, He ZY, Zhong XN, Cui ML. (18)FDG-PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer: a meta-analysis. Surg Oncol 2012; 21: 230-6.

3. Schmidt-Hansen M, Baldwin DR, Hasler E, Zamora J, Abraira V, Roqué I Figuls M. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst Rev 2014; 2014(11): CD009519.

4. Sara V, Jason MA, Angela T, Adam P, Giuseppe A, Aman SC. The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancer. Ann Transl Med 2018; 6: 95.

5. Erasmus JJ, Macapinlac HA. Low-sensitivity FDG-PET studies: less common lung neoplasms. Semin Nucl Med 2012; 42: 255-60.